首页> 外国专利> Pharmaceutical formulation, kit of parts, method for treating a patient suffering from or susceptible to a condition in which inhibition of thrombin and / or inhibition of carboxypeptidase u is required or desired, and, use of a formulation

Pharmaceutical formulation, kit of parts, method for treating a patient suffering from or susceptible to a condition in which inhibition of thrombin and / or inhibition of carboxypeptidase u is required or desired, and, use of a formulation

机译:药物制剂,零件盒,治疗患有或易感需要或希望抑制凝血酶和/或抑制羧肽酶u的病症的患者的方法,以及该制剂的用途

摘要

"PHARMACEUTICAL FORMULATION, KIT OF PARTS, METHOD FOR TREATING A PATIENT SUFFERING FROM OR SUSCEPTIBLE TO A CONDITION IN WHICH THE THROMBIN INHIBITION AND / OR INHIBITION OF CARBOXIPEPTIDASE IS REQUIRED OR DESIRED, AND, USE OF. The present invention relates to a carboxypeptidase U (CPU) inhibitor and a thrombin inhibitor, in admixture with a pharmaceutically acceptable adjuvant, diluent or carrier, as well as a kit of parts, a method for treating and using the formulations for treating a condition in which inhibition of the CPU and / or inhibition of thrombin is necessary or desired.
机译:“需要或希望抑制凝血酶和/或抑制羧肽酶的药物制剂,零件的试剂盒,治疗患有或易患病的患者的方法,本发明涉及一种羧肽酶与药学上可接受的佐剂,稀释剂或载体混合的CPU)抑制剂和凝血酶抑制剂,以及试剂盒,治疗和使用该制剂的方法,用于治疗其中对CPU有抑制作用和/或抑制作用的病症凝血酶的必要性或期望性。

著录项

  • 公开/公告号BR0010255A

    专利类型

  • 公开/公告日2002-02-13

    原文格式PDF

  • 申请/专利权人 ASTRAZENECA AB;

    申请/专利号BR20000010255

  • 申请日2000-05-03

  • 分类号A61K38/55;A61K31/095;A61P9/00;

  • 国家 BR

  • 入库时间 2022-08-22 00:46:15

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号